BioPharm International Supplements, January 2008 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International Supplements, January 2008
Articles
An Improved Manufacturing Process for a Recombinant Polyprotein Vaccine
By Thomas S. Vedvick , Lauren Carter , Garner Moulton , Yasuyuki Goto , Sylvie Bertholet , Steven G. Reed , Darrick Carter
The recombinant approach lends itself to the production of an inexpensive and effective vaccine at large scale.
Recombinant Vaccine Production in Yeast
By Georg Melmer , Gotthard Kunze , Gerd Gellissen
Human HBV can be grouped into eight genotypes, which differ by at least 8%.
Strategies to Improve Vaccines for the Neonate
By Volker Gerdts , George Mutwiri
Potential interference with maternally-derived antibodies makes most vaccines less effective in the neonate.
Needle-Free Methods of Vaccination
By Rocky Cranenburgh
Microstructured transdermal systems can deliver a vaccine in close proximity to the antigen-presenting cells in the epidermis.
Optimized Vaccine Development and Manufacturing: A Technology Overview
By Silke Fetzer
The replacement of a IgG ELISA assay with an SPR-based test can shorten the production workflow by one day.

ADVERTISEMENT

ADVERTISEMENT

Click here